Skip to main content
SG

S2 Genomics

S2 Genomics develops the Singulator™ Platform, an automated system for solid tissue dissociation that produces high-quality single-cell suspensions and intact nuclei in minutes. This technology addresses the variability and inefficiency of manual dissociation methods, ensuring reproducible results across over 80 tissue types with minimal cleanup.

Livermore, United StatesFounded 2016263K+ followers
Updated 20 months ago

Funding

$18.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

BCRC
Funding rounds are not available yet.

Founders

Product

Problem

Manual solid tissue dissociation methods for single-cell genomics are often variable and inefficient, leading to inconsistent results and compromising data quality. This variability can hinder the reliability of downstream genomic analyses and limit the reproducibility of research findings across different experiments and labs.

Solution

S2 Genomics offers the Singulator™ Platform, an automated system designed to streamline and standardize solid tissue dissociation for single-cell and single-nuclei applications. The platform automates the dissociation process, minimizing variability and ensuring consistent, high-quality single-cell suspensions and intact nuclei in minutes. By automating this critical step, the Singulator™ Platform enhances the reliability and reproducibility of single-cell genomics workflows, enabling researchers to generate dependable outputs for downstream genomic analyses. The system supports a wide range of tissue types and input amounts, offering customizable protocols to meet specific research needs.

Target Audience

The primary audience includes researchers and scientists in biotech, pharma, and academia involved in single-cell genomics research, seeking to improve the reliability and efficiency of their sample preparation workflows.

Features

  • Automated solid tissue dissociation for consistent and reproducible results
  • Compatible with over 80 tissue types, including fresh, frozen, OCT-preserved, and FFPE tissues
  • Customizable protocols to accommodate varying tissue types and research requirements
  • Minimal manual intervention and cleanup, reducing hands-on time and potential for error
  • Precise instrumentation and user-friendly software for ease of use
  • Capability to process input amounts as small as 2 mg
  • Produces high-quality single-cell suspensions and intact nuclei for downstream genomic analyses
This profile is AI-generated and may contain inaccuracies.